GlassScriptPhysician profile
Stephanie Heiser
NPI 1699328427
$10,123.48
in general payments reported to CMS, 2019-2025
48 companies · $1,275 in 2025
The $1,275 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,211 · 2022: $1,011 · 2023: $409 · 2024: $217 · 2025: $1,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $986 · Food and Beverage: $580 · Education: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $986.20 |
| Food and Beverage | $580.15 |
| Education | $335.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Upsher-Smith Laboratories LLC | $2,883.89 | 2021-2022 | |
| Intuitive Surgical, INC. | $1,103.19 | 2025 | |
| Abbvie INC. | $717.50 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $673.53 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $507.24 | 2021-2022 | |
| Glaxosmithkline, LLC. | $437.59 | 2021-2022 | |
| Pfizer INC. | $373.59 | 2021-2022 | |
| Amgen INC. | $369.43 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $326.79 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $292.99 | 2021 | |
| Medical Device Business Services, INC. | $276.69 | 2023-2024 | Stratafix |
| Genentech USA, INC. | $234.97 | 2021-2022 | |
| Genzyme Corporation | $156.36 | 2021-2022 | |
| Pharming Healthcare, INC. | $144.70 | 2021 | |
| Csl Behring | $139.96 | 2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Heiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.